Cancer Patients during COVID-19 Pandemic: A Mini-Review

Since its emergence, coronavirus disease 2019 (COVID-19) has affected the entire world and all commerce and industries, including healthcare systems. COVID-19 adversely affects cancer patients because they are immunocompromised. Increased COVID-19 infection and shortage of medical supplies, beds and...

Full description

Saved in:
Bibliographic Details
Published in:Healthcare (Basel) 2023-01, Vol.11 (2), p.248
Main Authors: Linjawi, Maryam, Shakoor, Hira, Hilary, Serene, Ali, Habiba I, Al-Dhaheri, Ayesha S, Ismail, Leila Cheikh, Apostolopoulos, Vasso, Stojanovska, Lily
Format: Article
Language:English
Subjects:
Biomarkers
Cancer therapies
Chemotherapy
COVID-19
Cytokines
Hypoxia
Infections
Intensive care
Lung cancer
Mortality
Pandemics
Patients
Proteins
Review
Severe acute respiratory syndrome coronavirus 2
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c360t-b3db918dbe9c5dfd21018b194f674e798033588f9cc229f65aee00ddb17f90633
cites cdi_FETCH-LOGICAL-c360t-b3db918dbe9c5dfd21018b194f674e798033588f9cc229f65aee00ddb17f90633
container_end_page
container_issue 2
container_start_page 248
container_title Healthcare (Basel)
container_volume 11
creator Linjawi, Maryam
Shakoor, Hira
Hilary, Serene
Ali, Habiba I
Al-Dhaheri, Ayesha S
Ismail, Leila Cheikh
Apostolopoulos, Vasso
Stojanovska, Lily
description Since its emergence, coronavirus disease 2019 (COVID-19) has affected the entire world and all commerce and industries, including healthcare systems. COVID-19 adversely affects cancer patients because they are immunocompromised. Increased COVID-19 infection and shortage of medical supplies, beds and healthcare workers in hospitals affect cancer care. This paper includes a description of the existing research that shows the impact of COVID-19 on the management of cancer patients. Aged people with various chronic conditions such as cancer and comorbidities face more challenges as they have a greater risk of disease severity. COVID-19 has affected care delivery, including patient management, and has been responsible for increased mortality among cancer patients. Cancer patients with severe symptoms require regular therapies and treatment; therefore, they have a higher risk of exposure. Due to the risk of transmission, various steps were taken to combat this disease; however, they have affected the existing operational efficiency. Herein, we present the changing priorities during COVID-19, which also affected cancer care, including delayed diagnosis, treatment, and surgeries.
doi_str_mv 10.3390/healthcare11020248
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9859465</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2767211529</sourcerecordid><originalsourceid>FETCH-LOGICAL-c360t-b3db918dbe9c5dfd21018b194f674e798033588f9cc229f65aee00ddb17f90633</originalsourceid><addsrcrecordid>eNplUdtKxDAQDaKorP6AD1LwxZdqLm2a-CAs9QqKIuprSJPpbpZe1qRd8e_tsrp4mZcZmDOHc-YgdEDwCWMSn05BV93UaA-EYIppIjbQLqU0iyVmdPPHvIP2Q5jhoSRhgqXbaIdxnjFO0l2U5box4KNH3TlouhDZ3rtmEuUPr7cXMZHDorFQO3MWjaN717j4CRYO3vfQVqmrAPtffYReri6f85v47uH6Nh_fxYZx3MUFs4UkwhYgTWpLSwkmoiAyKXmWQCYFZiwVopTGUCpLnmoAjK0tSFZKzBkbofMV77wvarBm0Oh1pebe1dp_qFY79XvTuKmatAslRSoTng4Ex18Evn3rIXSqdsFAVekG2j4omnFBEyaH34zQ0R_orO19M9hbojJKSErlgKIrlPFtCB7KtRiC1TIa9T-a4ejwp431yXcQ7BOrKIop</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2767211529</pqid></control><display><type>article</type><title>Cancer Patients during COVID-19 Pandemic: A Mini-Review</title><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Linjawi, Maryam ; Shakoor, Hira ; Hilary, Serene ; Ali, Habiba I ; Al-Dhaheri, Ayesha S ; Ismail, Leila Cheikh ; Apostolopoulos, Vasso ; Stojanovska, Lily</creator><creatorcontrib>Linjawi, Maryam ; Shakoor, Hira ; Hilary, Serene ; Ali, Habiba I ; Al-Dhaheri, Ayesha S ; Ismail, Leila Cheikh ; Apostolopoulos, Vasso ; Stojanovska, Lily</creatorcontrib><description>Since its emergence, coronavirus disease 2019 (COVID-19) has affected the entire world and all commerce and industries, including healthcare systems. COVID-19 adversely affects cancer patients because they are immunocompromised. Increased COVID-19 infection and shortage of medical supplies, beds and healthcare workers in hospitals affect cancer care. This paper includes a description of the existing research that shows the impact of COVID-19 on the management of cancer patients. Aged people with various chronic conditions such as cancer and comorbidities face more challenges as they have a greater risk of disease severity. COVID-19 has affected care delivery, including patient management, and has been responsible for increased mortality among cancer patients. Cancer patients with severe symptoms require regular therapies and treatment; therefore, they have a higher risk of exposure. Due to the risk of transmission, various steps were taken to combat this disease; however, they have affected the existing operational efficiency. Herein, we present the changing priorities during COVID-19, which also affected cancer care, including delayed diagnosis, treatment, and surgeries.</description><identifier>ISSN: 2227-9032</identifier><identifier>EISSN: 2227-9032</identifier><identifier>DOI: 10.3390/healthcare11020248</identifier><identifier>PMID: 36673615</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Biomarkers ; Cancer therapies ; Chemotherapy ; COVID-19 ; Cytokines ; Hypoxia ; Infections ; Intensive care ; Lung cancer ; Mortality ; Pandemics ; Patients ; Proteins ; Review ; Severe acute respiratory syndrome coronavirus 2 ; Tumors</subject><ispartof>Healthcare (Basel), 2023-01, Vol.11 (2), p.248</ispartof><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c360t-b3db918dbe9c5dfd21018b194f674e798033588f9cc229f65aee00ddb17f90633</citedby><cites>FETCH-LOGICAL-c360t-b3db918dbe9c5dfd21018b194f674e798033588f9cc229f65aee00ddb17f90633</cites><orcidid>0000-0003-2685-1244 ; 0000-0001-6043-9283 ; 0000-0001-7186-4461 ; 0000-0001-6788-2771 ; 0000-0002-7634-3531 ; 0000-0003-3048-7481 ; 0000-0003-0441-7391</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2767211529/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2767211529?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,38493,43871,44566,53766,53768,74155,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36673615$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Linjawi, Maryam</creatorcontrib><creatorcontrib>Shakoor, Hira</creatorcontrib><creatorcontrib>Hilary, Serene</creatorcontrib><creatorcontrib>Ali, Habiba I</creatorcontrib><creatorcontrib>Al-Dhaheri, Ayesha S</creatorcontrib><creatorcontrib>Ismail, Leila Cheikh</creatorcontrib><creatorcontrib>Apostolopoulos, Vasso</creatorcontrib><creatorcontrib>Stojanovska, Lily</creatorcontrib><title>Cancer Patients during COVID-19 Pandemic: A Mini-Review</title><title>Healthcare (Basel)</title><addtitle>Healthcare (Basel)</addtitle><description>Since its emergence, coronavirus disease 2019 (COVID-19) has affected the entire world and all commerce and industries, including healthcare systems. COVID-19 adversely affects cancer patients because they are immunocompromised. Increased COVID-19 infection and shortage of medical supplies, beds and healthcare workers in hospitals affect cancer care. This paper includes a description of the existing research that shows the impact of COVID-19 on the management of cancer patients. Aged people with various chronic conditions such as cancer and comorbidities face more challenges as they have a greater risk of disease severity. COVID-19 has affected care delivery, including patient management, and has been responsible for increased mortality among cancer patients. Cancer patients with severe symptoms require regular therapies and treatment; therefore, they have a higher risk of exposure. Due to the risk of transmission, various steps were taken to combat this disease; however, they have affected the existing operational efficiency. Herein, we present the changing priorities during COVID-19, which also affected cancer care, including delayed diagnosis, treatment, and surgeries.</description><subject>Biomarkers</subject><subject>Cancer therapies</subject><subject>Chemotherapy</subject><subject>COVID-19</subject><subject>Cytokines</subject><subject>Hypoxia</subject><subject>Infections</subject><subject>Intensive care</subject><subject>Lung cancer</subject><subject>Mortality</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Proteins</subject><subject>Review</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Tumors</subject><issn>2227-9032</issn><issn>2227-9032</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><recordid>eNplUdtKxDAQDaKorP6AD1LwxZdqLm2a-CAs9QqKIuprSJPpbpZe1qRd8e_tsrp4mZcZmDOHc-YgdEDwCWMSn05BV93UaA-EYIppIjbQLqU0iyVmdPPHvIP2Q5jhoSRhgqXbaIdxnjFO0l2U5box4KNH3TlouhDZ3rtmEuUPr7cXMZHDorFQO3MWjaN717j4CRYO3vfQVqmrAPtffYReri6f85v47uH6Nh_fxYZx3MUFs4UkwhYgTWpLSwkmoiAyKXmWQCYFZiwVopTGUCpLnmoAjK0tSFZKzBkbofMV77wvarBm0Oh1pebe1dp_qFY79XvTuKmatAslRSoTng4Ex18Evn3rIXSqdsFAVekG2j4omnFBEyaH34zQ0R_orO19M9hbojJKSErlgKIrlPFtCB7KtRiC1TIa9T-a4ejwp431yXcQ7BOrKIop</recordid><startdate>20230113</startdate><enddate>20230113</enddate><creator>Linjawi, Maryam</creator><creator>Shakoor, Hira</creator><creator>Hilary, Serene</creator><creator>Ali, Habiba I</creator><creator>Al-Dhaheri, Ayesha S</creator><creator>Ismail, Leila Cheikh</creator><creator>Apostolopoulos, Vasso</creator><creator>Stojanovska, Lily</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7XB</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>KB0</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2685-1244</orcidid><orcidid>https://orcid.org/0000-0001-6043-9283</orcidid><orcidid>https://orcid.org/0000-0001-7186-4461</orcidid><orcidid>https://orcid.org/0000-0001-6788-2771</orcidid><orcidid>https://orcid.org/0000-0002-7634-3531</orcidid><orcidid>https://orcid.org/0000-0003-3048-7481</orcidid><orcidid>https://orcid.org/0000-0003-0441-7391</orcidid></search><sort><creationdate>20230113</creationdate><title>Cancer Patients during COVID-19 Pandemic: A Mini-Review</title><author>Linjawi, Maryam ; Shakoor, Hira ; Hilary, Serene ; Ali, Habiba I ; Al-Dhaheri, Ayesha S ; Ismail, Leila Cheikh ; Apostolopoulos, Vasso ; Stojanovska, Lily</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c360t-b3db918dbe9c5dfd21018b194f674e798033588f9cc229f65aee00ddb17f90633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Biomarkers</topic><topic>Cancer therapies</topic><topic>Chemotherapy</topic><topic>COVID-19</topic><topic>Cytokines</topic><topic>Hypoxia</topic><topic>Infections</topic><topic>Intensive care</topic><topic>Lung cancer</topic><topic>Mortality</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Proteins</topic><topic>Review</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Linjawi, Maryam</creatorcontrib><creatorcontrib>Shakoor, Hira</creatorcontrib><creatorcontrib>Hilary, Serene</creatorcontrib><creatorcontrib>Ali, Habiba I</creatorcontrib><creatorcontrib>Al-Dhaheri, Ayesha S</creatorcontrib><creatorcontrib>Ismail, Leila Cheikh</creatorcontrib><creatorcontrib>Apostolopoulos, Vasso</creatorcontrib><creatorcontrib>Stojanovska, Lily</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database (ProQuest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Healthcare (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Linjawi, Maryam</au><au>Shakoor, Hira</au><au>Hilary, Serene</au><au>Ali, Habiba I</au><au>Al-Dhaheri, Ayesha S</au><au>Ismail, Leila Cheikh</au><au>Apostolopoulos, Vasso</au><au>Stojanovska, Lily</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cancer Patients during COVID-19 Pandemic: A Mini-Review</atitle><jtitle>Healthcare (Basel)</jtitle><addtitle>Healthcare (Basel)</addtitle><date>2023-01-13</date><risdate>2023</risdate><volume>11</volume><issue>2</issue><spage>248</spage><pages>248-</pages><issn>2227-9032</issn><eissn>2227-9032</eissn><abstract>Since its emergence, coronavirus disease 2019 (COVID-19) has affected the entire world and all commerce and industries, including healthcare systems. COVID-19 adversely affects cancer patients because they are immunocompromised. Increased COVID-19 infection and shortage of medical supplies, beds and healthcare workers in hospitals affect cancer care. This paper includes a description of the existing research that shows the impact of COVID-19 on the management of cancer patients. Aged people with various chronic conditions such as cancer and comorbidities face more challenges as they have a greater risk of disease severity. COVID-19 has affected care delivery, including patient management, and has been responsible for increased mortality among cancer patients. Cancer patients with severe symptoms require regular therapies and treatment; therefore, they have a higher risk of exposure. Due to the risk of transmission, various steps were taken to combat this disease; however, they have affected the existing operational efficiency. Herein, we present the changing priorities during COVID-19, which also affected cancer care, including delayed diagnosis, treatment, and surgeries.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>36673615</pmid><doi>10.3390/healthcare11020248</doi><orcidid>https://orcid.org/0000-0003-2685-1244</orcidid><orcidid>https://orcid.org/0000-0001-6043-9283</orcidid><orcidid>https://orcid.org/0000-0001-7186-4461</orcidid><orcidid>https://orcid.org/0000-0001-6788-2771</orcidid><orcidid>https://orcid.org/0000-0002-7634-3531</orcidid><orcidid>https://orcid.org/0000-0003-3048-7481</orcidid><orcidid>https://orcid.org/0000-0003-0441-7391</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2227-9032
ispartof Healthcare (Basel), 2023-01, Vol.11 (2), p.248
issn 2227-9032
2227-9032
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9859465
source Publicly Available Content Database; PubMed Central; Coronavirus Research Database
subjects Biomarkers
Cancer therapies
Chemotherapy
COVID-19
Cytokines
Hypoxia
Infections
Intensive care
Lung cancer
Mortality
Pandemics
Patients
Proteins
Review
Severe acute respiratory syndrome coronavirus 2
Tumors
title Cancer Patients during COVID-19 Pandemic: A Mini-Review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T14%3A50%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cancer%20Patients%20during%20COVID-19%20Pandemic:%20A%20Mini-Review&rft.jtitle=Healthcare%20(Basel)&rft.au=Linjawi,%20Maryam&rft.date=2023-01-13&rft.volume=11&rft.issue=2&rft.spage=248&rft.pages=248-&rft.issn=2227-9032&rft.eissn=2227-9032&rft_id=info:doi/10.3390/healthcare11020248&rft_dat=%3Cproquest_pubme%3E2767211529%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c360t-b3db918dbe9c5dfd21018b194f674e798033588f9cc229f65aee00ddb17f90633%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2767211529&rft_id=info:pmid/36673615&rfr_iscdi=true